AS · est 1996OsloParent · 1 subsidiary
Brreg · companies
headcount series appears after two register changes
Roles from Brreg, shown for business contact only. No birth date is shown or exported (purpose limitation, GDPR Art. 6(1)(f)).
Brreg · company_people
3 registered roles
| Styrets leder | Eirik Næss-Ulseth Multiple boards | 2010-09-16 | |
| Styremedlem | Frida Næss-Ulseth | 2010-09-16 | |
| Styremedlem | Selma Næss-Ulseth | 2010-09-16 |
NOK, amounts in thousands
| 2024 | 2025 | ||
|---|---|---|---|
| Revenue | 0 | ||
| Operating result | −339 | ||
| Result before tax | 187 | ||
| Net result | 187 | ||
| Total assets | 11 837 | ||
| Equity | 8 045 |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | 0 | ||||||
| Operating result | −339 | ||||||
| Result before tax | 187 | ||||||
| Net result | 187 | ||||||
| Total assets | 11 837 | ||||||
| Equity | 8 045 |
Regnskapsregisteret · company_revenue · FY2025 (company)
No corporate shareholders recorded.
Aksjonærregisteret · company_ownership · both directions
| 2024 | 2025 | 2026 | |
|---|---|---|---|
| auditor — | |||
| accountant KR ØKONOMI AS 2026-06-24 | ● |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|
| auditor — | |||||||
| accountant KR ØKONOMI AS 2026-06-24 | ● |
Brreg · company_org_roles
No recorded tender wins.
Relevant open tenders — matched · NACE 74.990 ↔ CPVsubscribers sharpen matches with per-company keywords
open-tender matching (NACE ↔ CPV) awaits Intelligo's open-tenders view
Doffin/TED · company_tender_wins · 2026-08-14
No job ads on record in the last 12 months.
NAV Arbeidsplassen · company_job_ad_months
Group revenue kr 1.08MGroup net kr -164kTenders won 0Rolled up across the parent + 1 subsidiary — Sharpxview AS alone is kr 1.08M.
rollup estimate · filed konsernregnskap not yet in Intelligo
| Sharpxview AS | 50% | Research and experimental development on natural sciences and engineering | kr 1.08M |
| Arctic Pharma AS | 36.8% | ||
| Vitae Evidence AS | 35.8% | ||
| Cellmover AS | 35.2% | ||
| Equanostic AS | 32.7% | ||
| Inventron AS | 28.0% | ||
| Rheumatech AS | 26.0% | ||
| Skiplukkern AS | 25% | ||
| Tobora AS | 25% | ||
| Coremine Vitae AS | 24.9% | ||
| Biomolex AS | 17.7% | ||
| Spermatech AS | 15.9% | ||
| 7.8% |
+3 more holdings
Aksjonærregisteret · company_ownership · both directions
This company's annual report has not been read yet. The filed figures above come from the accounts form; everything the board wrote around them is in the PDF, which is read on request.
Regnskapsregisteret (årsberetning) · company_annual_reports
registered 1996-06-24audit opt-out 2023-08-2822 14 18 68
Brreg · companies
register ledger · no events
No dated events on file
Skiwo · company_events